Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;42(8):514-521.

Cancer Immunotherapy, Part 3: Challenges and Future Trends

Cancer Immunotherapy, Part 3: Challenges and Future Trends

C Lee Ventola. P T. 2017 Aug.

Abstract

Despite dramatic breakthroughs, obstacles remain for the field of immunotherapy in cancer. These include the inability to predict treatment efficacy and patient response; the need for improved biomarkers; the development of resistance to immunotherapies; the lack of optimized clinical study designs; and high costs. Are solutions in sight?

PubMed Disclaimer

Figures

Figure 1
Figure 1
One-Year Per-Patient Costs for Treating Selected Cancers With Immune Checkpoint Blockers
Figure 2
Figure 2
One-Year Worldwide Costs for Treating Selected Cancers With Immune Checkpoint Blockers

References

    1. Alatrash G, Jakher H, Stafford PD, Mittendorf EA. Cancer immuno therapies, their safety and toxicity. Expert Opin Drug Saf. 2013;12(5):631–645. - PubMed
    1. Chiriva-Internati M, Bot A. A new era in cancer immunotherapy: discovering novel targets and reprogramming the immune system. Int Rev Immunol. 2015;34(2):101–103. - PubMed
    1. Yang Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest. 2015;125(9):3335–3337. - PMC - PubMed
    1. Pardoli D. Cancer and the immune system: basic concepts and targets for intervention. Semin Oncol. 2015;42(4):523–538. - PMC - PubMed
    1. Zugazagoitia J, Guedes C, Ponce S, et al. Current challenges in cancer treatment. Clin Ther. 2016;38(7):1551–1566. - PubMed

LinkOut - more resources